The effects of GLP-1 receptor agonists on body composition in patients with type 2 diabetes, overweight or obesity: A meta-analysis of randomized controlled trials
But doctors founds its weight loss benefits, and led to health agencies and organisations to approve some of these drugs for people who may be living with obesity or are overweight and battling health issues like high blood pressure, high cholesterol, or even sleep apnea
GLP-1 therapy improves appetite and metabolic function GLP-1 medications help regulate cravings, improve blood sugar control, and enhance metabolic efficiency
I help pharmacists start podcasts
When you pay $1,349 per month for Wegovy, you're partly paying for the decade of clinical trials that established its safety and efficacy in studied populations, the FDA premarket review that verified those studies, the standardized manufacturing that guarantees dose consistency from vial to vial, and the ongoing pharmacovigilance that monitors real-world adverse events